These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2305348)

  • 1. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ; MacLellan DG; Hashimoto T; Upp JR; Townsend CM; Thompson JC
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proglumide antagonizes the stimulation of rabbit gallbladder by cholecystokinin.
    Kaplita PV; Roebuck BD
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):271-6. PubMed ID: 6476983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist.
    Setnikar I; Bani M; Cereda R; Chisté R; Makovec F; Pacini MA; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1987 Jun; 37(6):703-7. PubMed ID: 3663268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminal cholecystokinin and gastrin cause gallbladder contraction.
    Brotschi EA; Vaules WA; Kahl EA; Midis NA; Hilbinger CL
    J Surg Res; 1996 May; 62(2):255-9. PubMed ID: 8632648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a novel CCK-antagonist (lorglumide) on human and guinea pig gallbladder strips: a tensiometric study.
    Portincasa P; Brandonisio R; Di Ciaula A; Maggi V; Chiloiro M; Palasciano G
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):567-73. PubMed ID: 2257123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a cholecystokinin antagonist, proglumide, on cholecystokinin-8-induced gallbladder contraction in conscious dogs.
    Fujimura M; Sakamoto T; Lluis F; Beauchamp RD; Townsend CM; Greeley GH; Thompson JC
    Biol Signals; 1992; 1(2):94-100. PubMed ID: 1307918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity.
    Makovec F; Chistè R; Bani M; Pacini MA; Setnikar I; Rovati LA
    Arzneimittelforschung; 1985; 35(7):1048-51. PubMed ID: 4052139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new and potent cholecystokinin antagonist on motor responses of the guinea-pig intestine.
    Barthó L; Holzer P; Lembeck F; Lippe IT; Setnikar I
    Br J Pharmacol; 1987 Apr; 90(4):753-61. PubMed ID: 3580706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Rovati L; Setnikar I
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cholecystokinin and its antagonists on the GI tract. Potent inhibition of gastrointestinal motility by loxiglumide].
    Schmidt WE
    Fortschr Med; 1992 Oct; 110(28):521-2. PubMed ID: 1398411
    [No Abstract]   [Full Text] [Related]  

  • 13. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal receptors for caerulein in gallbladder.
    Rakovska A; Milenov K
    J Physiol Paris; 1993; 87(6):355-7. PubMed ID: 8292986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
    Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S
    Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of loxiglumide (CR 1505) on CCK-induced contractions and 3H-acetylcholine release from guinea-pig gallbladder.
    Rakovska A; Sgaragli G; Mantovani P; Valoti M; Milenov K
    Neuropeptides; 1993 Nov; 25(5):271-6. PubMed ID: 8115030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholecystokinin activities of loxiglumide.
    Setnikar I; Bani M; Cereda R; Chisté R; Makovec F; Pacini MA; Revel L
    Arzneimittelforschung; 1987 Oct; 37(10):1168-71. PubMed ID: 3435589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK.
    Makovec F; Bani M; Cereda R; Chistè R; Pacini MA; Revel L; Rovati LC
    Pharmacol Res Commun; 1987 Jan; 19(1):41-51. PubMed ID: 3575382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.